Preface
Liquid biopsy in lung cancer: present and future
Translational Lung Cancer Research
2016;
5
(5)
:452-454
.
(31 October 2016)
Review Article
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
Translational Lung Cancer Research
2016;
5
(5)
:455-465
.
(31 October 2016)
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Translational Lung Cancer Research
2016;
5
(5)
:466-482
.
(31 October 2016)
Exosomes genetic cargo in lung cancer: a truly Pandora’s box
Translational Lung Cancer Research
2016;
5
(5)
:483-491
.
(31 October 2016)
Methylation analyses in liquid biopsy
Translational Lung Cancer Research
2016;
5
(5)
:492-504
.
(31 October 2016)
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
Translational Lung Cancer Research
2016;
5
(5)
:505-510
.
(31 October 2016)
KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
Translational Lung Cancer Research
2016;
5
(5)
:511-516
.
(31 October 2016)
Liquid biopsy in early stage lung cancer
Translational Lung Cancer Research
2016;
5
(5)
:517-524
.
(31 October 2016)
Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients
Translational Lung Cancer Research
2016;
5
(5)
:525-531
.
(31 October 2016)
Case Report
Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report
Translational Lung Cancer Research
2016;
5
(5)
:532-537
.
(31 October 2016)
Editorial
Pembrolizumab as first-line treatment for non-small cell lung cancer—a game changer?
Translational Lung Cancer Research
2016;
5
(5)
:538-542
.
(31 October 2016)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)2
What is better/reliable, mitosis counting or Ki67/MIB1 staining?
Translational Lung Cancer Research
2016;
5
(5)
:543-546
.
(31 October 2016)
Ki-67 expression in pulmonary tumors
Translational Lung Cancer Research
2016;
5
(5)
:547-551
.
(31 October 2016)
Ki-67 expression in pulmonary tumors—reply
Translational Lung Cancer Research
2016;
5
(5)
:552-553
.
(31 October 2016)
Tumor cell proliferation, proliferative index and mitotic count in lung cancer
Translational Lung Cancer Research
2016;
5
(5)
:554-556
.
(31 October 2016)
Meet the Professor3
Professor Rafael Rosell: curiosity for knowledge and passion for all human beings keep me motivated
Translational Lung Cancer Research
2016;
5
(5)
:557-560
.
(31 October 2016)
Disclosure:
1. The focused issue “Liquid Biopsy in Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Miguel Ángel Molina-Vila served as the unpaid Guest Editor for the focused issue.
2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
3. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
